UCB SA (UCBJF) Stock Forecast & Price Target

Compare

72 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UCBJF Analyst Ratings

Strong Buy

7 Buy

0 Hold

1 Sell

Based on 8 analysts giving stock ratings to

UCB

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UCBJF Stock 12 Month Forecast

Average Price Target

$318.52

▲(6.06% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for UCB SA in the last 3 months. The average price target is $318.52 with a high forecast of $361.40 and a low forecast of $247.15. The average price target represents a 6.06% change from the last price of $300.32.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"174":"$174","221":"$221","268":"$268","315":"$315","362":"$362"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":361.40234,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$361.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":318.52370108,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$318.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":247.152568,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$247.15</span>\n  </div></div>","useHTML":true}}],"tickPositions":[174,221,268,315,362],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,293.58,298.79710307692307,304.01420615384615,309.2313092307692,314.4484123076923,319.6655153846154,324.8826184615384,330.0997215384615,335.3168246153846,340.53392769230766,345.75103076923074,350.9681338461538,356.1852369230769,{"y":361.40234,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,293.58,295.49874623692307,297.41749247384615,299.33623871076924,301.2549849476923,303.1737311846154,305.0924774215385,307.0112236584615,308.9299698953846,310.8487161323077,312.76746236923077,314.68620860615385,316.60495484307694,{"y":318.52370108,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,293.58,290.00865907692304,286.43731815384615,282.8659772307692,279.2946363076923,275.72329538461537,272.1519544615385,268.58061353846153,265.0092726153846,261.4379316923077,257.86659076923075,254.29524984615384,250.72390892307692,{"y":247.152568,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":195.039,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.443,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.528,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.421,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":213.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.175,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.85,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":288.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":293.58,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$361.40

Average Price Target$318.52

Lowest Price Target$247.15

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Berenberg Bank

Not Ranked

Berenberg Bank

$338.09

Buy

12.58%

Upside

Reiterated

01/07/26

Berenberg Bank Sticks to Their Buy Rating for UCB SA (0NZT)

Charles Pitman CFA

Barclays

$314.77→$361.4

Buy

20.34%

Upside

Reiterated

01/06/26

UCB price target raised to EUR 310 from EUR 270 at BarclaysUCB price target raised to EUR 310 from EUR 270 at Barclays

Xian Deng

UBS

$349.74

Buy

16.46%

Upside

Reiterated

12/15/25

UCB SA (0NZT) Gets a Buy from UBS

Emmanuel Papadakis

Deutsche Bank

$332.26→$343.92

Buy

14.52%

Upside

Reiterated

12/08/25

UCB price target raised to EUR 295 from EUR 285 at Deutsche BankUCB price target raised to EUR 295 from EUR 285 at Deutsche Bank

Richard Vosser

J.P. Morgan

$268.14→$349.74

Buy

16.46%

Upside

Reiterated

12/08/25

UCB price target raised to EUR 300 from EUR 230 at JPMorganUCB price target raised to EUR 300 from EUR 230 at JPMorgan

Rajan Sharma

Goldman Sachs

$250→$255

Buy

-15.09%

Downside

Reiterated

12/05/25

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (NASDAQ: ADPT), UCB SA (LSE: GB:0NZT) and Cibus (NASDAQ: CBUS)

Sarita Kapila

Morgan Stanley

$279.8→$303.11

Buy

0.93%

Upside

Reiterated

12/03/25

Morgan Stanley Sticks to Its Buy Rating for UCB SA (0NZT)

Michael Leuchten

Jefferies

$247.15

Sell

-17.70%

Downside

Initiated

10/27/25

UCB assumed with an Underperform at JefferiesUCB assumed with an Underperform at Jefferies

Stacy Ku

TD Cowen

$297.28→$349.74

Buy

16.46%

Upside

Reiterated

10/09/25

TD Cowen Sticks to Its Buy Rating for UCB SA (0NZT)

Unknown Analyst

Bernstein

Not Ranked

Bernstein

$229.67

Hold

-23.53%

Downside

Reiterated

09/30/25

Bernstein Sticks to Their Hold Rating for UCB SA (0NZT)

David Evans

Kepler Capital

$171.37

Hold

-42.94%

Downside

Reiterated

07/31/25

Kepler Capital Reaffirms Their Hold Rating on UCB SA (0NZT)

Charlie Haywood

Bank of America Securities

$244.82→$262.31

Buy

-12.66%

Downside

Upgraded

07/02/25

Bank of America Securities upgrades UCB SA (0NZT) to a Buy

Peter Verdult

Exane BNP Paribas

$212.18

Buy

-29.35%

Downside

Reiterated

06/27/25

Exane BNP Paribas Sticks to Their Buy Rating for UCB SA (0NZT)

Unknown Analyst

Intron Health

Not Ranked

Intron Health

$250.65

Buy

-16.54%

Downside

Initiated

06/10/25

UCB SA (0NZT) Receives a Buy from Intron Health

Rajesh Kumar

HSBC

$236.66→$208.68

Buy

-30.51%

Downside

Reiterated

04/28/25

UCB price target lowered to EUR 179 from EUR 203 at HSBCUCB price target lowered to EUR 179 from EUR 203 at HSBC

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Berenberg Bank

Not Ranked

Berenberg Bank

$338.09

Buy

12.58%

Upside

Reiterated

01/07/26

Berenberg Bank Sticks to Their Buy Rating for UCB SA (0NZT)

Charles Pitman CFA

Barclays

$314.77→$361.4

Buy

20.34%

Upside

Reiterated

01/06/26

UCB price target raised to EUR 310 from EUR 270 at BarclaysUCB price target raised to EUR 310 from EUR 270 at Barclays

Xian Deng

UBS

$349.74

Buy

16.46%

Upside

Reiterated

12/15/25

UCB SA (0NZT) Gets a Buy from UBS

Emmanuel Papadakis

Deutsche Bank

$332.26→$343.92

Buy

14.52%

Upside

Reiterated

12/08/25

UCB price target raised to EUR 295 from EUR 285 at Deutsche BankUCB price target raised to EUR 295 from EUR 285 at Deutsche Bank

Richard Vosser

J.P. Morgan

$268.14→$349.74

Buy

16.46%

Upside

Reiterated

12/08/25

UCB price target raised to EUR 300 from EUR 230 at JPMorganUCB price target raised to EUR 300 from EUR 230 at JPMorgan

Rajan Sharma

Goldman Sachs

$250→$255

Buy

-15.09%

Downside

Reiterated

12/05/25

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (NASDAQ: ADPT), UCB SA (LSE: GB:0NZT) and Cibus (NASDAQ: CBUS)

Sarita Kapila

Morgan Stanley

$279.8→$303.11

Buy

0.93%

Upside

Reiterated

12/03/25

Morgan Stanley Sticks to Its Buy Rating for UCB SA (0NZT)

Michael Leuchten

Jefferies

$247.15

Sell

-17.70%

Downside

Initiated

10/27/25

UCB assumed with an Underperform at JefferiesUCB assumed with an Underperform at Jefferies

Stacy Ku

TD Cowen

$297.28→$349.74

Buy

16.46%

Upside

Reiterated

10/09/25

TD Cowen Sticks to Its Buy Rating for UCB SA (0NZT)

Unknown Analyst

Bernstein

Not Ranked

Bernstein

$229.67

Hold

-23.53%

Downside

Reiterated

09/30/25

Bernstein Sticks to Their Hold Rating for UCB SA (0NZT)

David Evans

Kepler Capital

$171.37

Hold

-42.94%

Downside

Reiterated

07/31/25

Kepler Capital Reaffirms Their Hold Rating on UCB SA (0NZT)

Charlie Haywood

Bank of America Securities

$244.82→$262.31

Buy

-12.66%

Downside

Upgraded

07/02/25

Bank of America Securities upgrades UCB SA (0NZT) to a Buy

Peter Verdult

Exane BNP Paribas

$212.18

Buy

-29.35%

Downside

Reiterated

06/27/25

Exane BNP Paribas Sticks to Their Buy Rating for UCB SA (0NZT)

Unknown Analyst

Intron Health

Not Ranked

Intron Health

$250.65

Buy

-16.54%

Downside

Initiated

06/10/25

UCB SA (0NZT) Receives a Buy from Intron Health

Rajesh Kumar

HSBC

$236.66→$208.68

Buy

-30.51%

Downside

Reiterated

04/28/25

UCB price target lowered to EUR 179 from EUR 203 at HSBCUCB price target lowered to EUR 179 from EUR 203 at HSBC

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UCB SA

3 Months

xxx

Success Rate

13/13 ratings generated profit

Average Return

+21.96%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +21.96% per trade.

1 Year

Xian DengUBS

Success Rate

16/16 ratings generated profit

Average Return

+47.40%

reiterated a buy rating last month

Copying Xian Deng's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +47.40% per trade.

2 Years

xxx

Success Rate

13/13 ratings generated profit

Average Return

+84.26%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +84.26% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UCBJF Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UCBJF has received 18 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. UCBJF average Analyst price target in the past 3 months is 318.52.

Each month's total comprises the sum of three months' worth of ratings.

UCBJF Financial Forecast

UCBJF Earnings Forecast

Next quarter’s earnings estimate for UCBJF is $5.59 with a range of $5.18 to $5.99. The previous quarter’s EPS was $4.11. UCBJF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year UCBJF has Performed in-line its overall industry.

UCBJF Sales Forecast

Next quarter’s sales forecast for UCBJF is $4.65B with a range of $4.33B to $4.97B. The previous quarter’s sales results were $4.06B. UCBJF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year UCBJF has Performed in-line its overall industry.

UCBJF Stock Forecast FAQ

What is UCBJF’s average 12-month price target, according to analysts?

Based on analyst ratings, UCB SA’s 12-month average price target is 318.52.

What is UCBJF’s upside potential, based on the analysts’ average price target?

UCB SA has 6.06% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UCBJF a Buy, Sell or Hold?

UCB SA has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 1 sell ratings.

What is UCB SA’s price target?

The average price target for UCB SA is 318.52. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $361.40 ,the lowest forecast is $247.15. The average price target represents 6.06% Increase from the current price of $300.32.

What do analysts say about UCB SA?

UCB SA’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of UCBJF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

UCB SA (UCBJF) Stock Forecast & Price Target

UCBJF Analyst Ratings

UCBJF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UCB SA

UCBJF Analyst Recommendation Trends

UCBJF Financial Forecast

UCBJF Earnings Forecast

UCBJF Sales Forecast

UCBJF Stock Forecast FAQ

Detailed List of Analyst Forecasts